EP4746870A2 - Auf proteolyse gerichtete chimäre zur behandlung von neurodegeneration - Google Patents

Auf proteolyse gerichtete chimäre zur behandlung von neurodegeneration

Info

Publication number
EP4746870A2
EP4746870A2 EP24843920.0A EP24843920A EP4746870A2 EP 4746870 A2 EP4746870 A2 EP 4746870A2 EP 24843920 A EP24843920 A EP 24843920A EP 4746870 A2 EP4746870 A2 EP 4746870A2
Authority
EP
European Patent Office
Prior art keywords
alkyl
conjugate
formula
disease
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24843920.0A
Other languages
English (en)
French (fr)
Inventor
Changning Wang
Stephen Neil GOMPERTS
Ping Bai
Tim Bartels
Vikram Khurana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
The Brigham and Women's Hospital Inc
General Hospital Corp
Original Assignee
UCL Business Ltd
The Brigham and Women's Hospital Inc
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd, The Brigham and Women's Hospital Inc, General Hospital Corp filed Critical UCL Business Ltd
Publication of EP4746870A2 publication Critical patent/EP4746870A2/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP24843920.0A 2023-07-18 2024-07-17 Auf proteolyse gerichtete chimäre zur behandlung von neurodegeneration Pending EP4746870A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363527519P 2023-07-18 2023-07-18
PCT/US2024/038408 WO2025019604A2 (en) 2023-07-18 2024-07-17 Proteolysis targeting chimeras for treating neurodegeneration

Publications (1)

Publication Number Publication Date
EP4746870A2 true EP4746870A2 (de) 2026-05-27

Family

ID=94282595

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24843920.0A Pending EP4746870A2 (de) 2023-07-18 2024-07-17 Auf proteolyse gerichtete chimäre zur behandlung von neurodegeneration

Country Status (4)

Country Link
EP (1) EP4746870A2 (de)
JP (1) JP2026524953A (de)
CN (1) CN122206430A (de)
WO (1) WO2025019604A2 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3710430B9 (de) * 2017-11-15 2024-10-30 Metabomed Ltd Acss2-hemmer und verfahren zur verwendung
AU2021214148A1 (en) * 2020-01-30 2022-07-14 Anima Biotech Inc. Collagen 1 translation inhibitors and methods of use thereof
CN118613257A (zh) * 2021-12-23 2024-09-06 鲁汶大学 用于抑制yap/taz-tead的四氢吡唑并嘧啶及相关类似物
WO2023122782A2 (en) * 2021-12-23 2023-06-29 The Katholieke Universiteit Leuven Indoles, indazoles, and related analogs for inhibiting yap/taz-tead

Also Published As

Publication number Publication date
WO2025019604A2 (en) 2025-01-23
CN122206430A (zh) 2026-06-12
WO2025019604A3 (en) 2025-04-24
JP2026524953A (ja) 2026-07-24

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20260306

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR